ALEXANDRIA, Va., July 16 -- United States Patent no. 12,361,542, issued on July 15, was assigned to TEMPUS AI INC. (Chicago).

"Systems and methods for deep orthogonal fusion for multimodal prognostic biomarker discovery" was invented by Nathaniel Braman (Cleveland), Jagadish Venkataraman (Menlo Park, Calif.) and Emery T. Goossens (Midvale, Utah).

According to the abstract* released by the U.S. Patent & Trademark Office: "A system and method are provided for identifying a multimodal biomarker of a prognostic prediction, using a deep learning framework trained to analyze different modality data, including radiomic image data, pathology image data, and molecular image data to obtain unimodal embedding predictions from those modality data and...